French cohort study of an extra-vascular ICD
Part of Heart & circulation clinical trials.
This study follows patients who receive a new type of implantable defibrillator that sits outside the heart and blood vessels. It aims to collect information about how well the device works and how safe it is over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are scheduled to receive an extra-vascular implantable cardioverter defibrillator (EV-ICD).
- You are willing and able to provide your consent to join the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study registers patients who have had or will have an extravascular implantable cardioverter-defibrillator (EV-ICD) placed. It aims to track how the device performs and any complications in real-world use.
This study follows people who are scheduled to get a new ICD (a device that helps protect the heart) and asks about their experiences and quality of life. It may help doctors understand what patients feel and how people do after ICD implantation.
This study tests a new type of defibrillator that goes underneath the skin, near your breastbone, to protect against dangerous heart rhythms. It may be an option if you need an ICD but haven't had certain prior chest surgeries or devices.
This study looks at an implantable defibrillator (ICD) strategy in people who survived a cardiac arrest caused by an abnormal rhythm (ventricular fibrillation or ventricular tachycardia). It aims to reduce the risk of another dangerous rhythm after the blocked heart arteries are fully treated.
This study looks at whether implantable defibrillators can reduce dangerous heart rhythms in people with non-ischemic cardiomyopathy (heart weakness not caused by blocked heart arteries), a heart scar, and very low pumping strength despite best treatment. It compares different approaches to choosing which patients should receive these devices.
This study keeps a long-term record of people who get an ICD (a device that helps treat dangerous heart rhythms) and its lead. It may help doctors learn how ICD leads perform over time.
Hear when a new Defibrillators, Implantable trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.